 |
 |
院長：牧田 善二
Doctor: Zenji Makita |
|
|
 |
研究の業績
| 発表年 |
種別 |
タイトル・掲載の詳細 |
| 2003年 |
原著 |
82)Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H.
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
Biochem J. 2003 Mar 15;370(Pt 3):1097-109.
|
| |
原著 |
83)Miura J, Yamagishi S, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z , Iwamoto Y.
Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
J Diabetes Complications. 2003 Jan-Feb;17(1):16-21. |
| |
原著 |
84)Kikuchi S, Shinpo K, Tsuji S, Takeuchi M, Yamagishi S, Makita Z , Niino M, Yabe I, Tashiro K.
Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons.
Brain Res. 2003 Feb 28;964(2):228-36. |
|
|
